Changes in plasma protein binding have little clinical relevance

@article{Benet2002ChangesIP,  title={Changes in plasma protein binding have little clinical relevance},  author={Leslie Z. Benet and Betty‐ann Hoener},  journal={Clinical Pharmacology \& Therapeutics},  year={2002},  volume={71},  url={https://api.semanticscholar.org/CorpusID:6948454}}
It is necessary to select patients suitable for vaginal or laparoscopic mesh placement for use in the neonatal intensive care unit based on prior history and once they provide informed consent for surgery.

776 Citations

Infusion of albumin attenuates changes in serum protein binding of drugs in surgical patients compared with volume replacement with HAES

Background: In vitro studies have indicated that stabilizers present in pharmaceutical‐grade albumin influence albumin‐binding capacity for highly protein bound drugs.

Drug Dosing in Patients With Impaired Renal Function

This review discusses the principles underlying disposition responses, with particular emphasis on how changes in disposition parameters affect dosing decisions.

Clinical pharmacokinetics of imatinib mesylate.

This review presents the clinical pharmacokinetics of imatinib mesylate. Aspects regarding absorption, tissue distribution, elimination and kinetic interactions are also discussed.

Pharmacokinetic considerations for drugs administered in the critically ill.

A case-based review of physiological changes common among critically ill patients and the consequences of these changes on the selection and dosing of medications is described.

Clinical Drug‐Drug Interactions

This article focuses on the pharmacokinetic-based DDIs, which are extremely detrimental to the patients and constitute as a major concern to the health care providers.

Lack of effect of lacosamide on the pharmacokinetic and pharmacodynamic profiles of warfarin

The aim of this study was to evaluate the effect of the antiepileptic drug lacosamide on the pharmacokinetics and pharmacodynamics of the anticoagulant warfarin.

Finding time for allosteric interactions

A chromatographic method characterizes allosteric interactions between drugs and their targets and indicates the importance of knowing the carrier and removal status of these substances.

Understanding Disease–Drug Interactions in Cancer Patients: Implications for Dosing Within the Therapeutic Window

The theory of how cancer can lead to indirect changes in drug metabolism is reviewed, acute phase proteins and cytokines are reviewed as markers of changes in cytochrome P450 (CYP) activity in cancer patients, and clinical case examples of how the inflammation in advanced cancer patients can Lead to altered CYP‐mediated drug clearance are provided.
...

17 References

Basic Clinical Pharmacokinetics

Basic clinical pharmacokinetics / , Basic clinical pharmacokinetics / , کتابخانه دیجیتال جندی شاپور اهواز

Plasma protein displacement interactions are rarely of clinical significance.

Drug interactions in general have been overemphasized with respect to both frequency and clinical importance and in those interactions where displacement has been most convincingly shown and a clinically important consequence ensues, an additional interaction mechanism has been present.

Commentary: a physiological approach to hepatic drug clearance.

A physiological approach has been developed recognizing that hepatic blood flow, the activity of the overall elimination process (intrinsic clearance), drug binding in the blood, and the anatomical…

Plasma protein binding displacement interactions--why are they still regarded as clinically important?

The purpose of this article is to review the likely clinical importance of plasma protein binding displacement interactions and to suggest an algorithm for investigating potential interactions, and to encourage teachers of therapeutics and drug regulators to regardprotein binding displacement with the minor degree of attention it deserves.

Potentiation of anticoagulant effect of warfarin by phenylbutazone.

THE administration of the pyrazolone derivatives, phenylbutazone and oxyphenbutazone, to a patient already being treated with coumarin anticoagulant drugs can lead to serious hemorrhagic…

Interaction between diflunisal and warfarin

Diflunisal reduced both the maximum plasma protein‐binding capacity for warfarin and the apparent association constant and there was a correlation between plasma diflunaisal and percentage unbound warFarin.

Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations.

The pharmacokinetics and urinary metabolic profile of R and S-warfarin, following administration of a 1.5 mg/kg oral dose of racemic warfarin and 4 days into an oral regimen of 100 mg phenylbutazone three times a day, and the stereoselective reduction of S- and R-warFarin, to their respective SS and RS-alcohols, is also substantially inhibited during phenyl butazone administration are investigated.

Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

We propose a model of drug pharmacodynamic response that when integrated with a pharmacokinetic model allows characterization of the temporal aspects of pharmacodynamics as well as the…

Related Papers

Showing 1 through 3 of 0 Related Papers